Clinical Trials Directory

Trials / Completed

CompletedNCT03395665

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

Status
Completed
Phase
Study type
Observational
Enrollment
299 (actual)
Sponsor
Fundacion Dexeus · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers

Summary

The development and improvement in Preimplantation genetic diagnosis/screening (PGS) in association with the efficacy and security of vitrification and trophectoderm biopsy, more efficient stimulation schemes and laboratory improvements in culture and embryo selection have contributed to high success of the assisted reproductive technologies(ART). Transferring an euploid embryo avoids one of the main reasons of miscarriage and implantation failure ( Rubio et al, 22016) and overcomes one of the most important confounding factors. Usually, the transfer of euploid embryos is performed under standard hormone replacement therapy (HRT) and are referred to as FET-PGS cycles( Frozen embryo transfer). The study of FET-PGS cycles with the transfer of a single euploid blastocyst is the best model for evaluation of the impact of the endometrial preparation . Among factors influencing FET outcomes, patient's age, endometrial preparation, endometrium thickness, endometrial pattern, number and quality of embryos transferred , difficulty at ET, recently P4 have received more attention . The importance of Progesterone (P4) in embryo implantation has been widely studied. P4 plays an important role in endometrial gland formation, embryonic implantation and pregnancy maintenance, both in natural and artificial cycles.

Conditions

Interventions

TypeNameDescription
OTHEREstradiol levelEstradiol level measured at previous day of embryo transfer procedure
OTHERProgesterone levelProgesterone level measured at previous day of embryo transfer procedure
OTHEREndometrial thicknessEndometrial thickness measured at previous day of embryo transfer procedure

Timeline

Start date
2014-01-01
Primary completion
2017-12-01
Completion
2018-01-01
First posted
2018-01-10
Last updated
2018-02-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03395665. Inclusion in this directory is not an endorsement.